Marcin Frąckiewicz

LIVEMarkets rolling coverageStarted: April 10, 2026, 12:00 AM EDTUpdated: April 10, 2026, 11:59 PM EDT Orora ASX:ORA Faces Earnings Reset After Saverglass Impact and Middle East Disruptions April 10, 2026, 11:59 PM EDT. Orora (ASX:ORA) shares plunged over 8% in one day following a guidance update that revealed an earnings reset at its Saverglass unit due to Middle East supply chain disruptions and a shutdown at the Ras Al Khaimah glass plant. Despite a sharp short-term loss, Orora's 90-day share price rise exceeds 33%, contrasting a longer-term 10.58% annual total shareholder return decline amid ongoing sector pressures. Trading at A$1.49,

LIVEMarkets rolling coverageStarted: April 9, 2026, 12:00 AM EDTUpdated: April 9, 2026, 11:59 PM EDT AngloGold Ashanti Shares Rise 192% Over Year, Valuation Near Fair Value April 9, 2026, 11:59 PM EDT. AngloGold Ashanti's stock surged 192% over the past year, closing at $108.55. Its valuation, measured by a Discounted Cash Flow (DCF) analysis, suggests a fair value of $119.76 per share, indicating the share price is about 9.4% below intrinsic value-neither a clear bargain nor overpriced. The company's free cash flow is projected to grow to $3.8 billion by 2029. Price-to-Earnings (P/E) ratios remain a key metric for investors

LIVEMarkets rolling coverageStarted: April 7, 2026, 12:00 AM EDTUpdated: April 7, 2026, 11:58 PM EDT Boston Scientific (BSX) Shares Hit 45% Discount; Undervalued Despite 34.7% YTD Drop April 7, 2026, 11:58 PM EDT. Boston Scientific's (BSX) share price has fallen 34.7% year to date, now trading around $61.86, down 31.8% over the past year. Despite this pullback, a discounted cash flow (DCF) analysis values the stock at approximately $112.50, suggesting a 45% undervaluation. Free cash flow forecasts rise from $3.63 billion to $6.84 billion by 2029, underpinning the bullish DCF outlook. The stock trades at a price-to-earnings (P/E) ratio of

LIVEMarkets rolling coverageStarted: April 5, 2026, 12:00 AM EDTUpdated: April 5, 2026, 11:59 PM EDT Lunnon Metals Faces 12-Month Cash Runway Amid Rising Cash Burn April 5, 2026, 11:59 PM EDT. Lunnon Metals (ASX:LM8) held AU$9.7 million in cash as of December 2025, matching its annual cash burn, giving it approximately a 12-month cash runway. The company, still in early stages with no revenue reported in the past year, has increased its cash burn by 24%, reflecting heightened business investment. With a market capitalization of AU$76 million, the cash burn represents about 13% of the firm's value, suggesting it could

LIVEMarkets rolling coverageStarted: April 4, 2026, 12:00 AM EDTUpdated: April 4, 2026, 11:59 PM EDT HDFC Bank Shares Fall 25% YTD Amid Leadership Shakeup and Bond Mis-selling Allegations April 4, 2026, 11:49 PM EDT. HDFC Bank's share price has dropped 25% year-to-date, driven by the sudden resignation of part-time Chairman Atanu Chakraborty over ethical issues and allegations against executives for mis-selling additional tier-1 (AT-1) bonds. Despite these controversies, the bank posted strong year-on-year growth in advances, deposits, and CASA (current and savings account deposit ratio) as of early April 2026. Analysts describe the stock's decline as a 'reset phase' post-HDFC

LIVEMarkets rolling coverageStarted: March 31, 2026, 12:00 AM EDTUpdated: March 31, 2026, 11:57 PM EDT Nasdaq Top and Bottom Stocks at 2:45 p.m. EDT on March 31, 2026 March 31, 2026, 11:48 PM EDT. At 2:45 p.m. EDT on March 31, 2026, Nasdaq showcased a clear divide between its leading and lagging stocks. Market data sourced from ICE Data Services and FactSet highlighted which equities drove gains and which pressured the index. Investors track these metrics to gauge sector performance and market sentiment. Data integrity was ensured by FactSet, the SEC, and Quartr filings, with additional insights from TradingView. Coca-Cola

LIVEMarkets rolling coverageStarted: March 30, 2026, 12:00 AM EDTUpdated: March 30, 2026, 11:59 PM EDT Bombardier Share Price Volatility Sparks Valuation Debate Amid Divergent Market Signals March 30, 2026, 11:45 PM EDT. Bombardier (TSX:BBD.B) shares dropped 2.2% in one day and 17.7% over a month, stirring investor attention. Despite recent declines, the company has posted a robust 186.6% total return over one year and impressive five-year gains. The stock trades at CA$232.07, about 53% above its intrinsic value estimate of CA$47.40, raising questions about overvaluation. There's a stark contrast in valuation views: a narrative tags Bombardier as overvalued by nearly

LIVEMarkets rolling coverageStarted: March 29, 2026, 12:00 AM EDTUpdated: March 29, 2026, 11:59 PM EDT Kailera Biotech Plans IPO for Phase 3 Obesity Drug from Hengrui March 29, 2026, 11:59 PM EDT. Kailera Biotech, a well-funded biotech startup, is preparing for an initial public offering (IPO) as it advances its obesity drug candidate to Phase 3 trials. The move aims to enter a competitive market currently dominated by established players like Eli Lilly and Novo Nordisk. The company hopes the IPO will support continued development and commercialization efforts amid rising demand for effective obesity treatments. Undervalued Pet Sector Stock Rises